Agensys

Specializes in therapeutic antibody research and development in cancer.

Launch date

1997

Market cap

Enterprise valuation

€352m (Public information from Dec 2007)

Santa Monica California (HQ)

Date	Investors	Amount	Round
Oct 1999	Lombard Odier	$11.3m	Series B
Mar 2002	Lombard Odier HBM Partners Alta Partners Hambrecht & Quist Capital Management OrbiMed ReqMed Company Carnegie Asset Management Bear Stearns	$42.8m	Series C
Mar 2003	Silicon Valley Bank	$3.0m	Debt
Jul 2007	Nextech Venture Lombard Odier JAFCO Asia Alta Partners Tekla Capital Management Icon Ventures OrbiMed	$41.3m	Series D
Dec 2007	Astellas Pharma	$387m Valuation: $387m	Acquisition
Total Funding		€94.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Agensys